At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Hossein Borghaei, DO, MS, discussed the development of novel combinations of checkpoint inhibitors to better treat patients with refractory lung cancers.
At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Hossein Borghaei, DO, MS, discussed the development of novel combinations of checkpoint inhibitors to better treat patients with refractory lung cancers.
At the Great Debates & Updates...